Aldo Maggioni to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Aldo Maggioni has written about Angiotensin Receptor Antagonists.
Connection Strength
0.371
-
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019 10 24; 381(17):1609-1620.
Score: 0.062
-
Effect of ß-blockers on 1-year survival and hospitalizations in patients with heart failure and atrial fibrillation: results from ESC-HF Pilot and ESC-HF Long-Term Registry. Pol Arch Intern Med. 2018 11 30; 128(11):649-657.
Score: 0.058
-
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018 07; 11(7):e004962.
Score: 0.057
-
Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail. 2018 02; 20(2):345-354.
Score: 0.054
-
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. JACC Heart Fail. 2017 07; 5(7):471-482.
Score: 0.053
-
The year in cardiology 2016: heart failure. Eur Heart J. 2017 03 07; 38(10):705-711.
Score: 0.052
-
Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2019 10; 7(10):862-874.
Score: 0.015
-
Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry. Kardiol Pol. 2018; 76(7):1064-1072.
Score: 0.014
-
[Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005]. G Ital Cardiol (Rome). 2007 Feb; 8(2):102-6.
Score: 0.006